Analysis of Deoxyribonucleic Acid and Ribonucleic Acid Next-Generation Sequencing in Non-Small Cell Lung Cancer Patients Without Pathological Complete Response Following Neoadjuvant Immunotherapy

Not yet recruitingOBSERVATIONAL

Enrollment

300

Participants

Timeline

Start Date

September 20, 2025

Primary Completion Date

January 31, 2026

Study Completion Date

May 31, 2026

Conditions

NSCLC

Interventions

OTHER

Not applicable- observational study

Trial Locations (1)

Tianjin Medical University Cancer Institute and Hospital(Lead Center), Tianjin

All Listed Sponsors

lead

Tianjin Medical University Cancer Institute and Hospital

OTHER